Meghmani Organics Earnings Call Transcript: Key Takeaways
Meghmani Organics Q1 FY27 revenue fell 12% YoY to INR542cr, but consolidated PAT jumped 280% to INR48.2cr on improved margins and operational efficiencies.
- Call
- Guides 10% growth
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Meghmani Organics Q1 FY27 revenue fell 12% YoY to INR542cr, but consolidated PAT jumped 280% to INR48.2cr on improved margins and operational efficiencies.
Meghmani Organics reported Q1 FY27 consolidated revenue of ₹542.8 Cr, down 12% YoY, while EBITDA grew 46% to ₹97.9 Cr. Performance was driven by improved product mix despite macroeconomic uncertainties.
Meghmani Organics reported FY26 standalone revenue of ₹2,091cr (up 4% YoY) and EBITDA of ₹228.7cr (up 27% YoY). Strategy focuses on Brazil expansion and Nano-fertilizer growth.
Meghmani Organics reported FY26 consolidated revenue of ₹2,174 Cr, up 5% YoY, with PAT at ₹28.7 Cr. The company is pivoting towards high-margin Crop Nutrition (Nano Urea) and Titanium Dioxide segments.